PharmaReports: Cancer Immunotherapy
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
Showing results 101 - 150 of 159
- Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition
- Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
- Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020
- Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
- Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020
- Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
- Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017
- Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020
- Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017
- US Pharmaceutical Market Outlook 2011-2021
- Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
- Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
- Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
- Stakeholder Opinions: Melanoma
- Epidemiology: Cervical Cancer
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
- Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth
- Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
- Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
- Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
- Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical
- Hypopharyngeal Cancer - Pipeline Review, H2 2011
- Squamous Cell Carcinoma - Pipeline Review, H2 2011
- Osteosarcoma - Pipeline Review, H2 2011
- Pediatric Cancer - Pipeline Review, H2 2011
- Thymus Cancer - Pipeline Review, H2 2011
- Lip And Oral Cavity Cancer - Pipeline Review, H2 2011
- Carcinoma Of The Bile Duct - Pipeline Review, H2 2011
- Metastatic Brain Tumors - Pipeline Review, H2 2011
- Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Avastin (Liver Cancer) – Analysis and Forecasts to 2020
- Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Ramucirumab (Liver Cancer) – Analysis and Forecasts to 2020
- Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Esophageal Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development